The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of acute lymphoblastic leukemia in adults.
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of acute lymphoblastic leukemia in adults.
12th March 2010
American Society for Blood and Marrow Transplantation
American Society for Blood and Marrow Transplantation
Source: National Guidelines Clearinghouse
DISEASE/CONDITION(S)
Acute lymphoblastic leukemia (ALL)
GUIDELINE CATEGORY
- Assessment of Therapeutic Effectiveness
- Treatment
- Hematology
- Internal Medicine
- Oncology
- Pathology
- Health Plans
- Managed Care Organizations
- Patients
- Physicians
- To assemble and critically evaluate all the evidence regarding the role of cytotoxic therapy with hematopoietic stem cell transplantation (SCT) in the therapy of adult acute lymphoblastic leukemia (ALL)
- To make treatment recommendations based on the available evidence
- To identify discrepancies in study design or methodology among published studies that may impact the quality of the evidence
- To identify needed areas of research regarding SCT in the therapy of adult ALL
Keywords:
cytotoxic therapy, hematopoietic stem cell transplantation, treatment of acute lymphoblastic leukemia,
cytotoxic therapy, hematopoietic stem cell transplantation, treatment of acute lymphoblastic leukemia,
